Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women

Summary

The primary objective of this clinical study is to evaluate the effectiveness and safety of PH3 for the prevention of osteoporosis. The secondary objectives are to identify the optimal dosage for subsequent studies and to provide basis for the next confirmatory study in study design, endpoints, and study methodologies.

Timeline

Start

2008-02

Primary completion

2011-07

Completion

2011-07

Drugs

Indications